Viewing Study NCT03272256


Ignite Creation Date: 2025-12-24 @ 11:24 PM
Ignite Modification Date: 2026-01-03 @ 7:16 AM
Study NCT ID: NCT03272256
Status: COMPLETED
Last Update Posted: 2020-10-19
First Post: 2017-08-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Study of IM156 in Patients With Advanced Solid Tumor and Lymphoma
Sponsor: ImmunoMet Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module